• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Churchill Capital Corp XI - Class A Ordinary Shares (NQ:CCXI)

    10.26 +0.07 (+0.69%)
    Streaming Delayed Price Updated: 9:30 AM EST, Feb 17, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 185
    Open 10.26
    Bid (Size) 10.19 (1,000)
    Ask (Size) 10.27 (600)
    Prev. Close 10.19
    Today's Range 10.26 - 10.26
    52wk Range 10.07 - 10.45
    Shares Outstanding 71,355,872
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Two Down With Sanofi Bowing Out From Horizon Buyout Talks, Amgen Agrees To Buy For $116.5/Share ↗
     
    Via Benzinga
    News headline image
    How to Trade the High-Growth Biotech Sector in the Midst of a Bear Market ↗
    Biotech is an exciting and emerging space that’s attracted increasing investor interest in recent years. 
    Via Benzinga

    Performance

    More News

    Read More
    News headline image
    ChemoCentryx Announces Presentations at the 2022 American Society of Nephrology and American College of Rheumatology Annual Meetings
    From ChemoCentryx, Inc.
    Via GlobeNewswire
    News headline image
    Biotech Stocks Well-Positioned For The Fourth Quarter ↗
    Via Talk Markets
    News headline image
    ChemoCentryx: Q2 Earnings Insights ↗
    Via Benzinga
    News headline image
    ChemoCentryx Announces Upcoming Presentations for Orally Administered PD-L1 Inhibitor, CCX559, at the 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting
    From ChemoCentryx, Inc.
    Via GlobeNewswire
    News headline image
    These Were the Five Best And Worst Performing Mid-Cap Stocks In August 2022 ↗
    Via Talk Markets
    News headline image
    Here Are 10 Biotech Stocks — Including Catalyst And Viridian — That Would Have Netted You $10,000 More This Year ↗
    Via Investor's Business Daily
    News headline image
    Something Unusual Is Happening Right Now With Biotech Stocks Like Catalyst, Vertex, Neurocrine And BioMarin ↗
    Via Investor's Business Daily
    News headline image
    INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates ChemoCentryx, Inc.’s Directors and Officers for Breach of Fiduciary Duties – CCXI
    From Scott+Scott Attorneys at Law LLP
    Via Business Wire
    News headline image
    7 Dow Stocks With Superior Fundamentals ↗
    Via InvestorPlace
    News headline image
    Healthcare Sector Still Looks Good But Lacks Momentum ↗
    Via Talk Markets
    News headline image
    ChemoCentryx's Return On Capital Employed Insights ↗
    Via Benzinga
    News headline image
    INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates ChemoCentryx, Inc.’s Directors and Officers for Breach of Fiduciary Duties – CCXI
    From Scott+Scott Attorneys at Law LLP
    Via Business Wire
    News headline image
    10 Biotech Stocks Are Up 40% Or More This Year, Including Karuna, Axsome And Others ↗
    Via Investor's Business Daily
    News headline image
    Whither Small Caps After Fed’s Tough Talk? ↗
    Via Talk Markets
    News headline image
    Blistering-Hot Biotech Shopping Spree Continues: Alcon To Buy Aerie For $770 Million ↗
    Via Investor's Business Daily
    News headline image
    Check your Portfolio for Small Cap Weighting: Growth, Innovation or Speculation? ↗
    Via Talk Markets
    News headline image
    Why Jim Cramer Says This Financial Stock Is 'Terrific' ↗
    Via Benzinga
    News headline image
    Benzinga's Top Ratings Upgrades, Downgrades For August 10, 2022 ↗
    Via Benzinga
    News headline image
    Earnings Preview: ChemoCentryx ↗
    Via Benzinga
    News headline image
    Small Cap Biotechs Perk Up On Dealmaking ↗
    Via Talk Markets
    News headline image
    Stock Market Rally Mixed As Oil Prices Fall, Job Growth Hot: Weekly Review ↗
    Via Investor's Business Daily
    News headline image
    Where ChemoCentryx Stands With Analysts ↗
    Via Benzinga
    News headline image
    Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2022 ↗
    Via Benzinga

    Frequently Asked Questions

    Is Churchill Capital Corp XI - Class A Ordinary Shares publicly traded?
    Yes, Churchill Capital Corp XI - Class A Ordinary Shares is publicly traded.
    What exchange does Churchill Capital Corp XI - Class A Ordinary Shares trade on?
    Churchill Capital Corp XI - Class A Ordinary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Churchill Capital Corp XI - Class A Ordinary Shares?
    The ticker symbol for Churchill Capital Corp XI - Class A Ordinary Shares is CCXI on the Nasdaq Stock Market
    What is the current price of Churchill Capital Corp XI - Class A Ordinary Shares?
    The current price of Churchill Capital Corp XI - Class A Ordinary Shares is 10.26
    When was Churchill Capital Corp XI - Class A Ordinary Shares last traded?
    The last trade of Churchill Capital Corp XI - Class A Ordinary Shares was at 02/17/26 09:30 AM ET
    What is the market capitalization of Churchill Capital Corp XI - Class A Ordinary Shares?
    The market capitalization of Churchill Capital Corp XI - Class A Ordinary Shares is 732.11M
    How many shares of Churchill Capital Corp XI - Class A Ordinary Shares are outstanding?
    Churchill Capital Corp XI - Class A Ordinary Shares has 732M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.